Beijing Scitop (China) Today
| 300858 Stock | 13.60 0.12 0.89% |
Performance0 of 100
| Odds Of DistressLess than 1
|
Beijing Scitop is trading at 13.60 as of the 1st of February 2025, a 0.89 percent increase since the beginning of the trading day. The stock's open price was 13.48. Beijing Scitop has a very small chance of experiencing financial distress in the next few years, but has generated negative returns over the last 90 days. The performance scores are derived for the period starting the 2nd of January 2025 and ending today, the 1st of February 2025. Click here to learn more.
Business Domain Pharmaceuticals, Biotechnology & Life Sciences | Category Healthcare | Classification Health Care |
Beijing Scitop is entity of China. It is traded as Stock on SHE exchange. The company has 263.5 M outstanding shares. More on Beijing Scitop Bio
Moving against Beijing Stock
Follow Valuation Profit Patterns Odds of Bankruptcy
Check how we calculate scores
Beijing Stock Highlights
Most reasonable investors view market volatility as an opportunity to invest at a favorable price or to sell short against a bearish trend. Beijing Scitop's investment highlights are automatically generated signals that are significant enough to either complement your investing judgment regarding Beijing Scitop or challenge it. These highlights can help you better understand the position you are entering and avoid costly mistakes.
| Business Concentration | Biotechnology, Pharmaceuticals, Biotechnology & Life Sciences, Health Care, Health Care, Biotechnology, Biotechnology, Healthcare (View all Sectors) |
Beijing Scitop Bio (300858) is traded on Shenzhen Stock Exchange in China and employs 330 people. Beijing Scitop is listed under Biotechnology category by Fama And French industry classification. The company currently falls under 'Mid-Cap' category with a current market capitalization of 3.58 B. Market capitalization usually refers to the total value of a company's stock within the entire market. To calculate Beijing Scitop's market, we take the total number of its shares issued and multiply it by Beijing Scitop's current market price. To manage market risk and economic uncertainty, many investors today build portfolios that are diversified across equities with different market capitalizations. However, as a general rule, conservative investors tend to hold large-cap stocks, and those looking for more risk prefer small-cap and mid-cap equities. Beijing Scitop Bio operates under Biotechnology sector and is part of Health Care industry. The entity has 263.5 M outstanding shares.
Beijing Scitop generates positive cash flow from operations, but has no cash available
Check Beijing Scitop Probability Of Bankruptcy
Ownership AllocationBeijing Scitop holds a total of 263.5 Million outstanding shares. Beijing Scitop Bio retains significant amount of outstanding shares owned by insiders. An insider is usually defined as a CEO, other corporate executive, director, or institutional investor who own at least 10% of the company's outstanding shares. Since such a large part of the company is owned by insiders, it is advisable to analyze if each of these insiders have been buying or selling the stock in recent months. Please note that no matter how many assets the company secures, if the real value of the firm is less than the current market value, you may not be able to make money on it.
Check Beijing Ownership Details
Beijing Scitop Bio Risk Profiles
Although Beijing Scitop's alpha and beta are two of the key measurements used to evaluate Beijing Scitop's performance over the market, the standard measures of volatility play an important role as well.
| Mean Deviation | 1.87 | |||
| Standard Deviation | 2.43 | |||
| Variance | 5.91 | |||
| Risk Adjusted Performance | (0.07) |
Beijing Stock Against Markets
Be your own money manager
Our tools can tell you how much better you can do entering a position in Beijing Scitop without increasing your portfolio risk or giving up the expected return. As an individual investor, you need to find a reliable way to track all your investment portfolios. However, your requirements will often be based on how much of the process you decide to do yourself. In addition to allowing all investors analytical transparency into all their portfolios, our tools can evaluate risk-adjusted returns of your individual positions relative to your overall portfolio.Did you try this?
Run Odds Of Bankruptcy Now
Odds Of BankruptcyGet analysis of equity chance of financial distress in the next 2 years |
| All Next | Launch Module |
Beijing Scitop Corporate Management
Elected by the shareholders, the Beijing Scitop's board of directors comprises two types of representatives: Beijing Scitop inside directors who are chosen from within the company, and outside directors, selected externally and held independent of Beijing. The board's role is to monitor Beijing Scitop's management team and ensure that shareholders' interests are well served. Beijing Scitop's inside directors are responsible for reviewing and approving budgets prepared by upper management to implement core corporate initiatives and projects. On the other hand, Beijing Scitop's outside directors are responsible for providing unbiased perspectives on the board's policies.
| Jianjun Zhang | Deputy Mang | Profile | |
| Lingyu Zhang | Board GM | Profile | |
| Qimuge Sudu | Deputy Mang | Profile | |
| Weichen Bao | Deputy Manager | Profile |
Other Information on Investing in Beijing Stock
Beijing Scitop financial ratios help investors to determine whether Beijing Stock is cheap or expensive when compared to a particular measure, such as profits or enterprise value. In other words, they help investors to determine the cost of investment in Beijing with respect to the benefits of owning Beijing Scitop security.